{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:52:44Z","timestamp":1769151164293,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2020.100267","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T06:36:46Z","timestamp":1607409406000},"page":"100267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The multiple effects of aspirin in prostate cancer patients"],"prefix":"10.1016","volume":"26","author":[{"given":"S.N.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olaniyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0001","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur. Urol"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0002","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.eururo.2012.03.019","article-title":"Prostate cancer epidemic in sight?","volume":"61","author":"Schr\u00f6der","year":"2012","journal-title":"Eur. Urol"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0003","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"De Marzo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2020.100267_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3835(02)00524-4","article-title":"Cyclooxygenase-2 and prostate carcinogenesis","volume":"191","author":"Hussain","year":"2003","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C","article-title":"Expression of cyclooxygenase-2 in prostate carcinoma","volume":"89","author":"Yoshimura","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CEJ.0b013e328339648c","article-title":"Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer","volume":"19","author":"Tian","year":"2010","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0008","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0009","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","article-title":"Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level","volume":"49","author":"Veitonm\u00e4ki","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1741-7015-12-55","article-title":"Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.ctarc.2020.100267_bib0012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1477-3163.128185","article-title":"Novel agents in the management of castration resistant prostate cancer","volume":"13","author":"Chaturvedi","year":"2014","journal-title":"J. Carcinog"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1055-9965.EPI-18-0965","article-title":"Aspirin and non-aspirin NSAID use and prostate cancer incidence, mortality, and case fatality in the atherosclerosis risk in communities study","volume":"28","author":"Hurwitz","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0014","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.eururo.2017.01.044","article-title":"Regular aspirin use and the risk of lethal prostate cancer in the physicians\u2019 health study","volume":"72","author":"Downer","year":"2017","journal-title":"Eur. Urol"},{"issue":"10","key":"10.1016\/j.ctarc.2020.100267_bib0015","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/ijc.25811","article-title":"Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006","volume":"128","author":"Dhillon","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"9759","key":"10.1016\/j.ctarc.2020.100267_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0017","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0018","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1027","article-title":"Aspirin use reduces the risk of aggressive prostate cancer and disease recurrence in African-American men","volume":"26","author":"Smith","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.amjcard.2010.08.041","article-title":"Comparison of the racial\/ethnic prevalence of regular aspirin use for the primary prevention of coronary heart disease from the multi-ethnic study of atherosclerosis","volume":"107","author":"Sanchez","year":"2011","journal-title":"Am. J. Cardiol"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pds.3463","article-title":"Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population","volume":"23","author":"Zhou","year":"2014","journal-title":"Pharmacoepidemiol. Drug. Saf"},{"issue":"11","key":"10.1016\/j.ctarc.2020.100267_bib0021","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ijo.2014.25","article-title":"Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort","volume":"38","author":"Morimoto","year":"2014","journal-title":"Int. J. Obes"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0022","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J. Am. Coll. Cardiol"},{"issue":"2","key":"10.1016\/j.ctarc.2020.100267_bib0023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrurol.2011.219","article-title":"Aspirin and urologic cancer risk: an update","volume":"9","author":"Bosetti","year":"2012","journal-title":"Nat. Rev. Urol"},{"issue":"9","key":"10.1016\/j.ctarc.2020.100267_bib0024","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pros.20951","article-title":"Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations","volume":"69","author":"Murtola","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ctarc.2020.100267_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.2013.280","article-title":"Cancer chemoprevention: a rapidly evolving field","volume":"109","author":"Steward","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2020.100267_bib0026","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/carcin\/14.9.1737","article-title":"Cancer chemoprevention: principles and prospects","volume":"14","author":"Morse","year":"1993","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0027","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF03190034","article-title":"Mechanisms of aspirin chemoprevention of colorectal cancer","volume":"24","author":"Vainio","year":"1999","journal-title":"Eur. J. Drug. Metab. Pharmacokinet"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0029","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1464-410x.2000.00867.x","article-title":"Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment","volume":"86","author":"Madaan","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.ctarc.2020.100267_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68\u201369","author":"Morita","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0031","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0032","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pros.10152","article-title":"Cyclooxygenase-2 promotes prostate cancer progression","volume":"53","author":"Fujita","year":"2002","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0033","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb. Vasc. Biol"},{"issue":"17","key":"10.1016\/j.ctarc.2020.100267_bib0034","first-page":"3761","article-title":"Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas","volume":"58","author":"Hida","year":"1998","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0035","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0036","first-page":"991","article-title":"Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck","volume":"59","author":"Chan","year":"1999","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0037","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0038","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ctarc.2020.100267_bib0039","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-4295(01)01255-9","article-title":"The role of cyclooxygenase-2 in prostate cancer","author":"Kirschenbaum","year":"2001","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.ctarc.2020.100267_bib0040","first-page":"2223","article-title":"Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors","volume":"59","author":"Hong","year":"1999","journal-title":"Cancer Res"},{"issue":"S1","key":"10.1016\/j.ctarc.2020.100267_bib0041","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1016\/j.ijsu.2017.08.084","article-title":"Prostate cancer progression: aspirin induces toxicity in prostate cancer cell","volume":"47","author":"Olaniyi","year":"2017","journal-title":"Int. J. Surg"},{"issue":"S1","key":"10.1016\/j.ctarc.2020.100267_bib0042","doi-asserted-by":"crossref","first-page":"s103","DOI":"10.1016\/j.ijsu.2017.08.519","article-title":"High levels of cyclooxygenase-2 expression are associated with prostate cancer","volume":"47","author":"Olaniyi","year":"2017","journal-title":"Int. J. Surg"},{"issue":"12","key":"10.1016\/j.ctarc.2020.100267_bib0043","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1096\/fj.201600530R","article-title":"Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1","volume":"30","author":"Rauzi","year":"2016","journal-title":"FASEB J"},{"issue":"22","key":"10.1016\/j.ctarc.2020.100267_bib0044","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.18632\/oncotarget.8655","article-title":"Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells","volume":"7","author":"Guillem-Llobat","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.ctarc.2020.100267_bib0045","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ctarc.2020.100267_bib0046","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ctarc.2020.100267_bib0047","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1074\/mcp.O116.065219","article-title":"A proteomic approach to analyze the aspirin-mediated lysine acetylome","volume":"16","author":"Tatham","year":"2017","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.ctarc.2020.100267_bib0048","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1038\/srep07896","article-title":"Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP)","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0049","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1378\/chest.118.5.1470","article-title":"Aspirin and asthma","volume":"118","author":"Babu","year":"2000","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ctarc.2020.100267_bib0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bjp.0704927","article-title":"Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors","volume":"137","author":"Gray","year":"2002","journal-title":"Br. J. Pharmacol"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0051","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2012.1588","article-title":"Arachidonic acid metabolism in human prostate cancer","volume":"41","author":"Yang","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.ctarc.2020.100267_bib0052","first-page":"5","article-title":"Aspirin prevention of colorectal cancer: focus on NF-\u03baB signalling and the nucleolus","author":"Chen","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.ctarc.2020.100267_bib0053","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1038\/sj.onc.1209942","article-title":"Nuclear factor-\u03baB and inhibitor of \u03baB kinase pathways in oncogenic initiation and progression","volume":"25","author":"Bass\u00e8res","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0054","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/carcin\/bgl220","article-title":"Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer","volume":"28","author":"Stark","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctarc.2020.100267_bib0055","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4161\/cc.24637","article-title":"Cell cycle checkpoint regulators reach a zillion","volume":"12","author":"Yasutis","year":"2013","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0056","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"S1","key":"10.1016\/j.ctarc.2020.100267_bib0057","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1016\/j.ijsu.2018.05.725","article-title":"Prostate cancer progression: aspirin causes cell cycle quiescence in prostate cancer","volume":"55","author":"Olaniyi","year":"2018","journal-title":"Int. J. Surg"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0058","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/excr.1996.0023","article-title":"Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis","volume":"222","author":"Shiff","year":"1996","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.ctarc.2020.100267_bib0059","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/762178","article-title":"Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines","author":"Olivan","year":"2015","journal-title":"Biomed. Res. Int"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0060","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1158\/0008-5472.CAN-06-1038","article-title":"p38-mediated inactivation of cyclin D1\/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells","volume":"67","author":"Thoms","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2362.2000.00585.x","article-title":"The physiological role of the polyamines","volume":"30","author":"Wallace","year":"2000","journal-title":"Eur. J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.ctarc.2020.100267_bib0062","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00726-015-2143-6","article-title":"Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells","volume":"48","author":"Li","year":"2016","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0063","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1124\/mol.107.039610","article-title":"Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation","volume":"72","author":"Yoo","year":"2007","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.ctarc.2020.100267_bib0064","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","article-title":"Survivin, versatile modulation of cell division and apoptosis in cancer","volume":"22","author":"Altieri","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI42328","article-title":"The \u03b12\u03b21 integrin is a metastasis suppressor in mouse models and human cancer","volume":"121","author":"Ramirez","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0066","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3892\/ijo_00000302","article-title":"Reorganization of the integrin \u03b12 subunit controls cell adhesion and cancer cell invasion in prostate cancer","volume":"34","author":"Van Slambrouck","year":"2009","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.ctarc.2020.100267_bib0067","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2004.05.004","article-title":"Nitric-oxide-donating NSAIDs as agents for cancer prevention","volume":"10","author":"Rigas","year":"2004","journal-title":"Trends Mol. Med"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0068","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0069","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.ju.0000132367.02834.41","article-title":"Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3","volume":"172","author":"Royle","year":"2004","journal-title":"J. Urol"},{"key":"10.1016\/j.ctarc.2020.100267_bib0070","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/jnci\/djg058","article-title":"Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?","volume":"95","author":"Choy","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ctarc.2020.100267_bib0071","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2174\/0929867003374336","article-title":"Role of cyclooxygenases in angiogenesis","volume":"7","author":"Leahy","year":"2012","journal-title":"Curr. Med. Chem"},{"issue":"18","key":"10.1016\/j.ctarc.2020.100267_bib0072","first-page":"5040","article-title":"The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis","volume":"60","author":"Jacoby","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ctarc.2020.100267_bib0073","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ctarc.2020.100267_bib0074","first-page":"1377","article-title":"Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model","volume":"7","author":"Alshafie","year":"2000","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.ctarc.2020.100267_bib0075","first-page":"284","article-title":"Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer","volume":"27","author":"Dhawan","year":"2009","journal-title":"Urol. Oncol. Semin. Orig. Investig"},{"issue":"3 Pt 1","key":"10.1016\/j.ctarc.2020.100267_bib0076","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-5347(05)67321-1","article-title":"Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate caner in vivo","volume":"164","author":"Liu","year":"2000","journal-title":"J. Urol"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0077","first-page":"1636","article-title":"Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo","volume":"40","author":"Hossain","year":"2012","journal-title":"Int. J. Oncol"},{"key":"10.1016\/j.ctarc.2020.100267_bib0078","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc2351","article-title":"Prostate-specific antigen and prostate cancer: prediction, detection and monitoring","volume":"8","author":"Lilja","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2020.100267_bib0079","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1158\/1055-9965.EPI-10-0942","article-title":"Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort","volume":"19","author":"Brasky","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.ctarc.2020.100267_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0090-4295(96)00226-9","article-title":"The CaPSURE database: a methodology for clinical practice and research in prostate cancer","volume":"48","author":"Lubeck","year":"1996","journal-title":"Urology"},{"issue":"28","key":"10.1016\/j.ctarc.2020.100267_bib0081","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2011.41.0308","article-title":"Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy","volume":"30","author":"Choe","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2020.100267_bib0082","doi-asserted-by":"crossref","DOI":"10.1177\/1756287218816595","article-title":"Should aspirin be suspended prior to robot-assisted radical prostatectomy? A systematic review and meta-analysis","volume":"11","author":"Carneiro","year":"2019","journal-title":"Ther. Adv. Urol"},{"issue":"1","key":"10.1016\/j.ctarc.2020.100267_bib0083","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5301\/tj.5000424","article-title":"Impact of aspirin on clinical outcomes for African American men with prostate cancer undergoing radiation","volume":"102","author":"Osborn","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.ctarc.2020.100267_bib0084","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cct.2016.10.004","article-title":"ADD-ASPIRIN: a phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours","volume":"51","author":"Coyle","year":"2016","journal-title":"Contemp. Clin. Trials"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294220301027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294220301027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:20:43Z","timestamp":1762842043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294220301027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":84,"alternative-id":["S2468294220301027"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100267","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multiple effects of aspirin in prostate cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2020.100267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100267"}}